AA
IDXG

Ancora Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Ancora Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,479
Closed -$13K – 687
2017
Q2 		$13K Hold
1,479
– – ﹤0.01% 624
2017
Q1 		$39K Hold
1,479
– – ﹤0.01% 615
2016
Q4 		$65K Sell
1,479
-1,100
-43% -$35.1K ﹤0.01% 735
2016
Q3 		$41K Hold
2,579
– – ﹤0.01% 521
2016
Q2 		$85K Hold
2,579
– – 0.01% 499
2016
Q1 		$72K Hold
2,579
– – 0.01% 481
2015
Q4 		$120K Sell
2,579
-450
-15% -$50.1K 0.02% 470
2015
Q3 		$542K Hold
3,029
– – 0.07% 291
2015
Q2 		$433K Buy
+3,029
New +$420K 0.05% 344
2015
Q1 		– Sell
-1,550
Closed -$254K – 382
2014
Q4 		$277K Buy
+1,550
New +$276K 0.03% 406

Other funds holding IDXG

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM